YOU ARE HERE:
Side-effects news
page  of 17
 
Headline
Date
  Continued antiretroviral therapy reduces bone mineral density in SMART study
27.10.08
  Switching to AZT from d4T poses challenges in resource-limited settings
19.09.08
  Low CD4 cell count, but not HIV treatment, increases risk of hardening of the arteries
19.08.08
  Long-term HIV treatment cuts risk of hardening of coronary artery
19.08.08
  Heat-stable ritonavir tablet equivalent to soft gel capsule; may be approved next year
15.08.08
  SMART study and 54-trial pooled analysis produce conflicting data about abacavir heart attack link
08.08.08
  Urine biomarkers may predict cardiovascular disease in people taking antiretroviral therapy
07.08.08
  Need for vigilance: two cases of abacavir allergy despite pre-treatment screening all-clear
16.07.08
  One third of people with HIV have experienced sexual difficulties in the past month
15.07.08
  Important changes to nevirapine dosing advice made by FDA
03.07.08
  Acute kidney failure more common in people newly diagnosed with HIV
25.06.08
  Improvement in anaemia in majority of US patients after starting AZT reported in large review
24.06.08
  Impaired kidney function present in quarter of Zambians starting ART
05.06.08
  Low rate of toxicity-related treatment change suggests HIV treatment tolerable in the long-term
29.05.08
  Combining rifampicin with increased doses of lopinavir/ritonavir tablets leads to dangerous increases in liver enzymes
13.05.08
  Does tenofovir increase the risk of efavirenz-associated liver side-effects?
09.05.08
  Insulin resistance may predict risk of cardiovascular disease in HIV
08.05.08
  African-Americans with HIV have higher risk of aggressive kidney disease
07.05.08
  Higher CD4 cell counts associated with lower rate of non-HIV-related diseases in patients taking antiretrovirals
25.04.08
  Reducing d4T dose improves mitochondrial toxicity, but not lipoatrophy
16.04.08

page  of 17